Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$9,296,571
+$752,660 QoQ
Shares Held
36,605
+4.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#1,159
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $45,176,274 across 12 Drug Manufacturers - General names. JNJ ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
66,702 | $16,784,891 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
36,605 | $9,296,571 | |
| 3 | LLY |
ELI LILLY & Co
|
7,302 | $8,758,238 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,249 | $4,657,996 | |
| 5 | AMGN |
Amgen Inc
|
6,203 | $2,246,230 | |
| 6 | AZN |
Astrazeneca PLC
|
3,462 | $656,464 | |
| 7 | NVO |
Novo Nordisk A S
|
12,559 | $602,078 | |
| 8 | PFE |
Pfizer Inc
|
24,805 | $597,304 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,296,571 | 36,605 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,543,911 | 34,953 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,728,565 | 32,513 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,070,560 | 48,919 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,005,420 | 45,862 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $7,493,148 | 45,183 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,044,103 | 41,793 | Shares | Sole | 2025-04-22 | |
| 2024-09-30 | $7,642,587 | 47,159 | Shares | Sole | 2025-04-22 | |
| 2024-06-30 | $6,834,149 | 46,758 | Shares | Sole | 2025-04-22 | |
| 2024-03-31 | $7,358,840 | 46,519 | Shares | Sole | 2025-04-22 | |
| 2023-12-31 | $7,874,931 | 50,242 | Shares | Sole | 2025-04-22 | |
| 2023-09-30 | $4,123,325 | 26,474 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $3,365,021 | 20,330 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $3,646,685 | 23,527 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $4,447,517 | 25,177 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $4,473,940 | 27,387 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $5,451,332 | 30,710 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $5,517,701 | 31,133 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $5,980,093 | 34,957 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,194,970 | 32,167 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,012,873 | 30,429 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,809,045 | 29,261 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,482,025 | 28,479 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,382,580 | 29,437 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,037,065 | 28,707 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,759,103 | 28,667 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||